My career started over 31 years ago as a pharmaceutical representative. My experiences span the fields of Account Management, Corporate Training, Brand and Marketing Management, Pharmacy Benefit Management Services, Senior Health Care Director, Health Systems Account Management, District and Regional Field Management and National Accounts Director. These positions, as an amalgam, have provided me with a unique vantage point and exceptional business acumen relative to the transformation of the pharmaceutical industry and the emergence of new therapeutic entities. My investment strategy is a balance between dividend producing pharmaceutical manufacturers, tech companies, emerging markets and innovative niche-players who hold the promise of true innovation in the area of pharmaco and immuno-therapeutics.
Individual investor interested in dividend growth stocks and building an income producing portfolio to cover my yearly expenses. Also, interested in minimizing my expenses by practicing frugality, carefully planning my spending, and staying debt free.
Theodore J. Cohen, Ph.D., a research scientist, has been an investor for more than 50 years. Since 1980, he has focused his attention on investment research and investigative analyses of companies developing therapeutic drugs in the biotech sector. Dr. Cohen is a frequent contributor of Guest Opinions (op-ed pieces) to the Bucks County (PA) Courier Times (circulation: 80,000), where, since 2007, he has addressed such varied subjects as the conflicts of interest (COIs) associated with two members of the Provenge advisory committee (AC); the U.S. Senate’s Durbin Amendment, to tighten COI reviews of FDA AC members; and naked short selling. Cohen is the author of the award-winning novels Death by Wall Street: Rampage of the Bulls (AuthorHouse, 2010) and House of Cards: Dead Men Tell No Tales (Outskirts Press, 2011), which were inspired by real events. The books are available from Amazon.com, B&N, and 26,000 online bookstores worldwide. For details, see http://www.theodore-cohen-novels.com.
I am a former mutual fund industry trader from Boston. I've traded (among other things) for a slower life on the beach and golf course in sunny Florida. I hope you find my contributions interesting!
I'm the guilty conscience of all the world's overconfident stock tip subscription bloggers, financial advisors, hobbyists, and market pundits. In a rare moment of honest self-reflection, I admit that the following popular activities add no long term value compared to index funds:
Paying for stock tip subscriptions.
Obsessing about dividends or dividend streaks.
Scrounging income by selling options.
Forecasting interest rates, commodity prices, and stock market returns.
Paying an advisor 1% of assets under management to create a portfolio of mutual funds.
Following consensus superstitions such as support levels and resistance.
Believing that valuation graphs identify undervalued stocks.
Thinking that beating the S&P 500 for several years predicts future outperformance.
Laboriously building a portfolio that's like an existing no-effort ETF but without the benefit of diversification.
Seeking alpha has been one of the "go-to" sites for the investors in our family. We would like to strike a perfect balance between short term trading and long term investing, hence the name "Tradevestor".Good luck investing. In the interest of full disclosure, this is a group account handled by Father and Son. The Father was a trader for quite a few years years with mixed returns, while the son started out a few years ago with DGI and has slowly convinced the Patriarch towards investing rather than trading.
Disclaimer: Please do your own due diligence before buying or selling any stock. Ideas and thoughts presented in the articles are not professional recommendations.